Residual limits are often maintained as isolated calculations in spreadsheets. However, in complex pharmaceutical manufacturing environments, the challenge is much broader. Residual limits must be scientifically justified, consistently applied, traceable over time, and operationally enforced across the cleaning validation lifecycle.

This webinar explores why spreadsheet-driven approaches break down as product portfolios, equipment trains, toxicology inputs, and analytical requirements grow more complex. Attendees will examine the scientific and regulatory foundations of HBEL/PDE-based limits and MACO justification, and learn what it takes to manage residual limits as a governed system rather than a collection of disconnected files.

The discussion will outline the capabilities needed for a scalable digital model, including standardized calculation rules, product and equipment mapping, structured change control, periodic review, and audit-ready traceability.

Register to learn how a system-based approach can improve consistency, strengthen compliance, and help organizations turn residual limits management into a resilient enterprise capability rather than a site-level, manual exercise.